Patheon to invest $45 million in spray drying & manufacturing solutions
Patheon expects to invest approximately $45 million at key sites across its network in spray drying capabilities and flexible manufacturing solutions...
List view / Grid view
Patheon expects to invest approximately $45 million at key sites across its network in spray drying capabilities and flexible manufacturing solutions...
Following FDA legislation in 1999, scrutinising packaging standards for extractables and leachables has become the norm. In this whitepaper, Eurofins examines the ways in which the evaluation of final packaging components is now carried out including the role of liquid and gas chromatography-mass spectrometry in the process.
Wenzel Novak PhD gives some considerations on container, environment, process and automation for small batch sizes in the downstream process of fill-finish…
Aptar Pharma has announced the installation of manufacturing capacity for its child-resistant and Senior-Friendly Classic Nasal Pump in their Congers, NY site.
The Directive on Falsified Medicines (FMD, or Directive 2011/62/EU amending Directive 2001/83/EC) and its supplementing Delegated Regulation (DR 2016/161) aim to improve patient safety by preventing falsified medicines from entering the legal supply chain...
Plastic materials used in pharmaceutical packaging can interact with the packaged dosage form, causing leachables to accumulate...
Over 12 months ago, the European Union delegated regulation that supplements the Falsified Medicines Directive (FMD) was published in the Official Journal of the European Union, starting the countdown to the deadline of 9 February 2019, when most EU member-states, and three non-members currently, are expected to have implemented all…
Read the free-to-view digital version of the latest issue of European Pharmaceutical Review...
FMD and supply chain security; Strategic aspects of change control for pharmaceutical packaging systems; and does the Falsified Medicines Directive lead to a European pack coding guideline?
28 October 2016 | By ESP
Enterprise System Partners (ESP) has formally signed a partnership agreement with GS1 Ireland to work collaboratively in the development and delivery of the highest anti-counterfeiting solutions based on GS1 standards to the biopharmaceutical manufacturing industry...
28 October 2016 | By ESP
In collaboration with our partners GS1 Ireland, ESP carried out an extensive industry survey to establish the status of the industry in relation to the impending serialisation deadlines, which are facing us in the coming months and years...
In this issue: Biosimilars, Regulation, Packaging, Microfluidics, Microbiology, PAT, Antibiotic Resistance, and much more...
In this Pharmaceutical Packaging In-Depth Focus: End-to-end verification of the medicines supply chain; Understanding the financial implications of the upcoming falsified medicines regulations; Point of view on the evolution of labelling and packaging.
31 May 2016 | By Pharmapack
Pharmapack is a two-day exhibition and conference dedicated to pharmaceutical packaging, drug delivery and affiliated industries...